Union Chimique Belge

About:

UCB is a biopharma company that focuses on the research and development of medication for neurology and immunology diseases.

Website: http://www.ucb.com

Twitter/X: ucb_news

Top Investors: Paul Capital, Financière de Tubize SA

Description:

UCB focuses on research and development of medications centered on epilepsy, parkinson's disease, and crohn's disease. Their research and development activities in neurology, immunology, and other areas.